• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆组织因子阳性细胞外囊泡的测量:当前方法的优缺点。

Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods.

机构信息

UNC Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA.

出版信息

Curr Opin Hematol. 2022 Sep 1;29(5):266-274. doi: 10.1097/MOH.0000000000000730. Epub 2022 Jul 11.

DOI:10.1097/MOH.0000000000000730
PMID:35852819
Abstract

PURPOSE OF REVIEW

This review evaluates the different methods used to measure levels of tissue factor (TF) in plasma and on extracellular vesicles (EVs). Levels of TF-positive (TF+) EVs in blood are increased in a variety of diseases, such as cancer, sepsis, and viral infection, and are associated with thrombosis. Highly sensitive assays are required to measure the low levels of TF+ EVs in blood.

RECENT FINDINGS

TF antigen levels in plasma have been measured using standard ELISAs, SimpleStep ELISA technology, and solid-phase proximity ligation assay. Some studies reported the detection of TF+ EVs in plasma by flow cytometry. In addition, TF+ EVs can be captured onto beads and chips using anti-TF antibodies. Several assays have been developed to measure TF activity in EVs isolated from plasma. Importantly, activity-based assays are more sensitive than antigen-based assays as a single TF/FVIIa complex can generate large amounts of FXa.

SUMMARY

We recommend isolating EVs from plasma and measuring TF activity using a functional assay in the presence and absence of an anti-TF antibody. We do not recommend using antigen-based assays as these are not sensitive enough to detect the low levels of TF in plasma.

摘要

目的综述

本综述评估了用于测量血浆中和细胞外囊泡(EVs)中组织因子(TF)水平的不同方法。在各种疾病(如癌症、脓毒症和病毒感染)中,血液中 TF 阳性(TF+)EVs 的水平升高,并与血栓形成有关。需要高灵敏度的检测方法来测量血液中低水平的 TF+EVs。

最近的发现

使用标准 ELISA、SimpleStep ELISA 技术和固相邻近连接测定法测量血浆中的 TF 抗原水平。一些研究报告通过流式细胞术检测到血浆中的 TF+EVs。此外,可使用抗 TF 抗体将 TF+EVs 捕获到珠子和芯片上。已经开发了几种测定法来测量从血浆中分离的 EVs 中的 TF 活性。重要的是,基于活性的测定比基于抗原的测定更灵敏,因为单个 TF/FVIIa 复合物可以产生大量的 FXa。

总结

我们建议从血浆中分离 EVs,并在存在和不存在抗 TF 抗体的情况下使用功能测定法测量 TF 活性。我们不建议使用基于抗原的测定法,因为这些方法不够灵敏,无法检测到血浆中低水平的 TF。

相似文献

1
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods.血浆组织因子阳性细胞外囊泡的测量:当前方法的优缺点。
Curr Opin Hematol. 2022 Sep 1;29(5):266-274. doi: 10.1097/MOH.0000000000000730. Epub 2022 Jul 11.
2
Extracellular Vesicle Tissue Factor Activity Assay.细胞外囊泡组织因子活性测定法。
J Vis Exp. 2023 Dec 29(202). doi: 10.3791/65840.
3
Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology.比较测量血浆样本中外泌体组织因子的检测方法:ISTH SSC 血管生物学小组委员会的交流。
J Thromb Haemost. 2024 Oct;22(10):2910-2921. doi: 10.1016/j.jtha.2024.05.037. Epub 2024 Jun 25.
4
Detection of tissue factor-positive extracellular vesicles by laser scanning confocal microscopy.激光扫描共聚焦显微镜检测组织因子阳性细胞外囊泡。
Thromb Res. 2017 Feb;150:65-72. doi: 10.1016/j.thromres.2016.12.021. Epub 2016 Dec 23.
5
Evaluation of a new bead-based assay to measure levels of human tissue factor antigen in extracellular vesicles in plasma.评估一种基于微珠的新检测方法,用于测量血浆细胞外囊泡中人类组织因子抗原的水平。
Res Pract Thromb Haemost. 2022 Mar 4;6(2):e12677. doi: 10.1002/rth2.12677. eCollection 2022 Feb.
6
Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells.VIIa 因子诱导与整合素的相互作用控制组织因子从内皮细胞的细胞外囊泡中释放。
J Thromb Haemost. 2019 Apr;17(4):627-634. doi: 10.1111/jth.14406. Epub 2019 Mar 1.
7
Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and -dependent mechanisms.乳腺癌细胞外囊泡通过组织因子非依赖和依赖的机制诱导血小板的激活和聚集。
Thromb Res. 2017 Nov;159:24-32. doi: 10.1016/j.thromres.2017.09.019. Epub 2017 Sep 21.
8
Evaluation of the ability of commercial enzyme-linked immunosorbent assays to measure mouse tissue factor.评估商业酶联免疫吸附测定法检测小鼠组织因子的能力。
Res Pract Thromb Haemost. 2024 Jan 26;8(1):102325. doi: 10.1016/j.rpth.2024.102325. eCollection 2024 Jan.
9
Tissue factor activity of small and large extracellular vesicles in different diseases.不同疾病中小细胞外囊泡和大细胞外囊泡的组织因子活性
Res Pract Thromb Haemost. 2023 Mar;7(3):100124. doi: 10.1016/j.rpth.2023.100124. Epub 2023 Mar 15.
10
Procoagulant extracellular vesicles in amniotic fluid.羊水中的促凝血细胞外囊泡。
Transl Res. 2017 Jun;184:12-20.e1. doi: 10.1016/j.trsl.2017.01.003. Epub 2017 Feb 4.

引用本文的文献

1
Challenges with measuring tissue factor antigen and activity in human plasma.测量人血浆中组织因子抗原和活性的挑战。
Blood Vessel Thromb Hemost. 2024 Jul 31;1(4):100022. doi: 10.1016/j.bvth.2024.100022. eCollection 2024 Dec.
2
The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgery.卵巢癌手术后瑞舒伐他汀降低循环组织因子细胞外囊泡的疗效。
Blood Adv. 2025 Sep 9;9(17):4472-4476. doi: 10.1182/bloodadvances.2025016107.
3
Pathways regulating the levels of tissue factor-positive extracellular vesicles and activation of coagulation in endotoxemic mice.
调节内毒素血症小鼠组织因子阳性细胞外囊泡水平及凝血激活的信号通路。
J Thromb Haemost. 2025 Apr 24. doi: 10.1016/j.jtha.2025.04.012.
4
Histological differences among thrombi in thrombotic diseases.血栓形成性疾病中血栓的组织学差异。
Curr Opin Hematol. 2025 May 1;32(3):146-156. doi: 10.1097/MOH.0000000000000860. Epub 2025 Feb 7.
5
Microvesicle Tissue Factor Procoagulant Activity Is Elevated and Correlated With Disease Severity in Patients With Cirrhosis.微泡组织因子促凝活性在肝硬化患者中升高且与疾病严重程度相关。
Liver Int. 2025 Apr;45(4):e16192. doi: 10.1111/liv.16192. Epub 2024 Nov 27.
6
Activated Factor VII-Antithrombin Complex, a Biomarker of Tissue Factor-Related Pathways in Different Clinical Settings: A Narrative Review from Cardiovascular Diseases to Cancer.活化凝血因子VII-抗凝血酶复合物,不同临床环境中组织因子相关通路的生物标志物:从心血管疾病到癌症的叙述性综述
Diagnostics (Basel). 2024 Aug 6;14(16):1711. doi: 10.3390/diagnostics14161711.
7
Evaluation of the ability of commercial enzyme-linked immunosorbent assays to measure mouse tissue factor.评估商业酶联免疫吸附测定法检测小鼠组织因子的能力。
Res Pract Thromb Haemost. 2024 Jan 26;8(1):102325. doi: 10.1016/j.rpth.2024.102325. eCollection 2024 Jan.
8
Occult cancer in patients with unprovoked venous thromboembolism: A nested case-control study.不明原因静脉血栓栓塞症患者中的隐匿性癌症:巢式病例对照研究。
Am J Clin Pathol. 2024 May 2;161(5):501-511. doi: 10.1093/ajcp/aqad178.
9
Tissue factor pathway-related biomarkers in liver cancer: activated factor VII-antithrombin complex and tissue factor mRNA levels are associated with mortality.肝癌中组织因子途径相关生物标志物:活化因子VII-抗凝血酶复合物及组织因子mRNA水平与死亡率相关。
Res Pract Thromb Haemost. 2024 Jan 2;8(1):102310. doi: 10.1016/j.rpth.2023.102310. eCollection 2024 Jan.
10
Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer.组织因子途径抑制剂与癌症患者静脉血栓栓塞和全因死亡率相关。
Haematologica. 2024 Apr 1;109(4):1128-1136. doi: 10.3324/haematol.2023.283581.